Alex Taylor of Inductive Bio has spoken about the use of artificial intelligence in drug discovery, according to AI Magazine. The interview was published by the outlet on Sunday, 1 November 2026.
The discussion centres on how AI is being applied within the drug discovery process. AI Magazine presents the conversation with Taylor as a look at the technology's role in that field.
Inductive Bio is the company Taylor represents in the interview. Beyond that, the source material does not detail the specific methods, tools or findings discussed.
AI's use in pharmaceutical research has drawn growing attention as companies look for ways to speed up and inform the search for new treatments. The AI Magazine interview adds Taylor's perspective to that wider conversation.
The source material does not include the full text of the interview, so the specific points Taylor makes are not available here.
Readers interested in the detail of Taylor's remarks can find the full interview at AI Magazine. Further coverage of AI's application in drug discovery, and of Inductive Bio's work in particular, is worth watching as the company and the outlet share more.
